High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu

被引:37
作者
Kaneko, A
Kaneko, O
Taleo, G
Bjorkman, A
Kobayakawa, T
机构
[1] OSAKA CITY UNIV,SCH MED,DEPT MED ZOOL,OSAKA 545,JAPAN
[2] DEPT HLTH,MALARIA SECT,PORT VILA,VANUATU
[3] KAROLINSKA INST,DANDERYD HOSP,DIV INFECT DIS,STOCKHOLM,SWEDEN
关键词
D O I
10.1016/S0140-6736(05)62696-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:921 / 922
页数:2
相关论文
共 5 条
  • [1] GEOGRAPHICAL INTERRACIAL DIFFERENCES IN POLYMORPHIC DRUG OXIDATION - CURRENT STATE OF KNOWLEDGE OF CYTOCHROMES P450 (CYP) 2D6 AND 2C19
    BERTILSSON, L
    [J]. CLINICAL PHARMACOKINETICS, 1995, 29 (03) : 192 - 209
  • [2] DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594
  • [3] KATAYAMA K, 1990, MAN CULTURE OCEANIA, V6, P151
  • [4] Atovaquone and proguanil for Plasmodium falciparum malaria
    Radloff, PD
    Philipps, J
    Nkeyi, M
    Hutchinson, D
    Kremsner, PG
    [J]. LANCET, 1996, 347 (9014) : 1511 - 1514
  • [5] THE ACTIVATION OF THE BIGUANIDE ANTIMALARIAL PROGUANIL CO-SEGREGATES WITH THE MEPHENYTOIN OXIDATION POLYMORPHISM - A PANEL STUDY
    WARD, SA
    HELSBY, NA
    SKJELBO, E
    BROSEN, K
    GRAM, LF
    BRECKENRIDGE, AM
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) : 689 - 692